Angiodynamics (ANGO) Net Margin (2016 - 2025)
Historic Net Margin for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to 7.99%.
- Angiodynamics' Net Margin rose 67500.0% to 7.99% in Q4 2025 from the same period last year, while for Nov 2025 it was 9.02%, marking a year-over-year increase of 694200.0%. This contributed to the annual value of 11.62% for FY2025, which is 490400.0% up from last year.
- Per Angiodynamics' latest filing, its Net Margin stood at 7.99% for Q4 2025, which was up 67500.0% from 14.4% recorded in Q3 2025.
- Angiodynamics' Net Margin's 5-year high stood at 58.32% during Q3 2023, with a 5-year trough of 249.71% in Q1 2024.
- In the last 5 years, Angiodynamics' Net Margin had a median value of 11.21% in 2023 and averaged 22.1%.
- In the last 5 years, Angiodynamics' Net Margin plummeted by -2379600bps in 2024 and then surged by 2435900bps in 2025.
- Over the past 5 years, Angiodynamics' Net Margin (Quarter) stood at 10.67% in 2021, then increased by 7bps to 9.93% in 2022, then crashed by -270bps to 36.74% in 2023, then soared by 60bps to 14.74% in 2024, then skyrocketed by 46bps to 7.99% in 2025.
- Its Net Margin stands at 7.99% for Q4 2025, versus 14.4% for Q3 2025 and 7.55% for Q2 2025.